Document Detail

Congenital retroperitoneal vascular anomalies: impact on pelvic surgery.
MedLine Citation:
PMID:  21184091     Owner:  NLM     Status:  MEDLINE    
PURPOSE: Congenital anomalies of the inferior vena cava (IVC) are not commonly recognized since they generally do not cause symptoms.
METHODS: Preoperative cross-sectional imaging can identify anomalies of vascular structures that are highly relevant to the pelvic surgeon. The clinical impact of congenital vascular variations of IVC, especially on paraaortic lymphadenectomy, is investigated.
RESULTS: In case the surgeon is unaware of these anomalies, impending differential diagnostic confusion (paraaortic adenopathy), intraoperative blood loss and the need for transfusion may occur. The development of IVC is a complex process concerning the formation of several anastomoses between three paired embryonic veins (posterior cardinal, subcardinal, supracardinal veins). In double IVC, the left IVC typically ends at the level of the left renal vein, in an anastomosis which crosses anterior to the aorta to join the normal right IVC.
CONCLUSION: Anomalies of IVC are present in 0.4-3.5% of women. As different aberrations of IVC have important clinical implications, awareness of retroperitoneal abnormal vessels is crucial to avoid diagnostic pitfalls and intraoperative complications.
Alexander Strauss; Carolin Kuemper; Christoph Mundhenke; Fritz Schaefer; Walter Jonat; Felix Hilpert
Publication Detail:
Type:  Case Reports; Journal Article     Date:  2010-12-24
Journal Detail:
Title:  Archives of gynecology and obstetrics     Volume:  284     ISSN:  1432-0711     ISO Abbreviation:  Arch. Gynecol. Obstet.     Publication Date:  2011 Nov 
Date Detail:
Created Date:  2011-10-11     Completed Date:  2012-02-15     Revised Date:  2013-06-03    
Medline Journal Info:
Nlm Unique ID:  8710213     Medline TA:  Arch Gynecol Obstet     Country:  Germany    
Other Details:
Languages:  eng     Pagination:  1169-73     Citation Subset:  IM    
Department of Obstetrics and Gynaecology, Kiel University Hospital, Arnold-Heller-Strasse 3, Building 24, 24105 Kiel, Germany.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Adenocarcinoma, Papillary / blood supply*,  drug therapy,  radiography,  surgery
Antineoplastic Agents / therapeutic use
Antineoplastic Combined Chemotherapy Protocols / therapeutic use
Carboplatin / therapeutic use
Deoxycytidine / analogs & derivatives,  therapeutic use
Lymphatic Metastasis
Middle Aged
Ovarian Neoplasms / blood supply*,  drug therapy,  radiography,  surgery
Pelvis / blood supply*,  embryology,  surgery
Treatment Outcome
Vascular Malformations / embryology,  surgery
Vena Cava, Inferior / abnormalities*,  embryology,  surgery
Reg. No./Substance:
0/Antineoplastic Agents; 41575-94-4/Carboplatin; 951-77-9/Deoxycytidine; B76N6SBZ8R/gemcitabine

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  The use of extracorporeal magnetic innervation for the treatment of stress urinary incontinence in o...
Next Document:  Forensic and genetic characterization of mtDNA from Pathans of Pakistan.